SPBC215.01 Antibody

What is SPBC215.01 and why is it important in fission yeast research?

SPBC215.01 is a protein in Schizosaccharomyces pombe (fission yeast, strain 972/ATCC 24843) that likely plays a role in regulatory processes. While its specific function isn't completely characterized in the available literature, fission yeast serves as a valuable model organism for studying fundamental cellular processes. The protein is part of the extensive gene regulatory network in S. pombe that has been partially characterized through genome-wide expression studies . Using antibodies against SPBC215.01 allows researchers to investigate protein expression, localization, and interactions within this model system that shares several thousand orthologous genes with humans .

What experimental applications are suitable for SPBC215.01 antibody?

The SPBC215.01 antibody has been tested and validated for:

• Western blotting (WB) for protein expression analysis

• Enzyme-linked immunosorbent assay (ELISA)

The antibody is specifically raised against recombinant Schizosaccharomyces pombe SPBC215.01 protein and is reactive with S. pombe (strain 972/ATCC 24843) . Unlike some other antibodies, it has not been validated for immunohistochemistry-paraffin (IHC-P) or flow cytometry applications, which should be considered when designing experiments.

What are the optimal storage and handling conditions for SPBC215.01 antibody?

For maximum stability and activity:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles

• The antibody is supplied in liquid form

• Storage buffer composition: 50% Glycerol, 0.01M PBS (pH 7.4), with 0.03% Proclin 300 as preservative

This polyclonal antibody has been purified using antigen affinity methods, which impacts its specificity and application versatility compared to monoclonal alternatives.

How should I optimize Western blot protocols for SPBC215.01 detection in fission yeast lysates?

For optimal Western blot detection:

• Sample preparation:

  • Extract proteins using glass bead disruption in buffer containing 250 mM NaCl, 50 mM HEPES (pH 7.9), 80 mM β-glycerophosphate, 5 mM EDTA, 0.1% NP-40, and 10% glycerol

  • Use approximately 35 μg of total protein per lane

• Gel and transfer considerations:

  • Separate proteins on 8-10% SDS-PAGE (consider 200:1 acrylamide:bisacrylamide ratio for better resolution of proteins in the expected molecular weight range)

  • Transfer to PVDF membrane for optimal antibody binding

• Blocking and antibody incubation:

  • Use 5% non-fat milk or BSA in TBST

  • Incubate with SPBC215.01 antibody at proper dilution (start with manufacturer's recommendation and optimize as needed)

• Controls:

  • Include wild-type and deletion mutant (if available) controls to validate specificity

How can SPBC215.01 antibody be used to investigate protein-protein interactions in regulatory networks?

Co-immunoprecipitation (Co-IP) protocols can be adapted for SPBC215.01 interaction studies:

• Cell preparation and lysis:

  • Collect cells and resuspend in lysis buffer with protease inhibitors

  • Lyse cells by bead beating as described in previous studies

• Immunoprecipitation:

  • Incubate lysates with antibody-conjugated beads (e.g., Protein A/G)

  • Wash thoroughly with lysis buffer

  • Elute bound proteins for downstream analysis

• Analysis of interacting partners:

  • Perform mass spectrometry analysis to identify novel interaction partners

  • Validate specific interactions with Western blotting

  • Consider using chromatin immunoprecipitation (ChIP) if SPBC215.01 is suspected to associate with DNA

This approach would be similar to methods used to identify protein interactions in fission yeast regulatory networks, where protein complexes have been identified through affinity purification followed by mass spectrometry .

What are the methodological challenges in studying SPBC215.01 during cell cycle progression?

Several considerations should be addressed:

• Cell synchronization methods:

  • Choose appropriate synchronization techniques (temperature-sensitive mutants, elutriation, or chemical blocks) depending on your specific research question

  • Note that different synchronization methods may affect protein expression and modification states

• Temporal resolution:

  • Sample collection at multiple timepoints is critical for capturing dynamic changes

  • Based on studies of cell cycle-regulated genes in fission yeast, consider sampling every 15-20 minutes to capture key transitions

• Protein modification detection:

  • Phosphorylation state may change during cell cycle, requiring phospho-specific detection methods

  • Consider combining standard Western blotting with Phos-tag™ gels to detect mobility shifts indicative of phosphorylation

• Localization changes:

  • If available, use GFP-tagged versions for live cell imaging during cell cycle progression

  • Standard DAPI staining can be used for nuclear visualization as described in fission yeast protocols

How can I verify SPBC215.01 antibody specificity and rule out cross-reactivity with other proteins?

Multiple validation approaches should be employed:

• Genetic controls:

  • Compare antibody signal between wild-type and deletion mutant samples if available

  • Use overexpression systems to confirm increased signal intensity

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide before application

  • Specific signal should be significantly reduced or eliminated

• Signal verification across techniques:

  • Confirm consistent molecular weight detection between Western blot and immunoprecipitation

  • Multiple antibodies recognizing different epitopes of the same protein should yield similar results

• Cross-species reactivity testing:

  • Test antibody against closely related species (e.g., other Schizosaccharomyces species) to establish specificity boundaries

  • Note that the current SPBC215.01 antibody is raised specifically against S. pombe (strain 972/ATCC 24843)

What are the common technical issues when using SPBC215.01 antibody and how can they be addressed?

How does SPBC215.01 fit into broader studies of fission yeast gene regulation and cell cycle control?

SPBC215.01 should be considered in the context of broader cellular regulatory networks:

• Global gene regulation:

  • Fission yeast has been extensively studied for transcriptional responses to environmental stresses

  • Consider whether SPBC215.01 expression changes during stress conditions or cell cycle progression

  • Integrate findings with known regulatory modules from genome-wide studies

• Cell cycle checkpoint analysis:

  • Fission yeast contains important checkpoint mechanisms including those regulated by Chk1 and Cds1 kinases

  • Investigate whether SPBC215.01 is involved in checkpoint responses by examining protein levels or modifications after checkpoint activation

• Evolutionary conservation:

  • Consider whether SPBC215.01 has homologs in other species including humans

  • If conservation exists, this may suggest fundamental cellular functions worthy of further investigation

What are the emerging techniques that could enhance SPBC215.01 research beyond traditional antibody applications?

Several cutting-edge approaches should be considered:

• CRISPR-based tagging strategies:

  • Endogenous tagging allows visualization and purification under native expression conditions

  • Consider epitope tags (FLAG, HA) or fluorescent protein fusions (GFP, mCherry)

• Proximity labeling techniques:

  • BioID or TurboID fusions can identify proteins in close proximity to SPBC215.01

  • This approach may reveal transient interactions missed by traditional co-IP

• Single-cell protein analysis:

  • Microfluidics-based approaches can reveal cell-to-cell variability in protein expression

  • Time-lapse imaging with tagged proteins can reveal dynamic behaviors

• Structural studies:

  • If recombinant protein can be produced, consider structural determination via X-ray crystallography or cryo-EM

  • Structural insights could reveal functional domains and interaction interfaces

• Integration with transcriptomics and proteomics:

  • Combine antibody-based studies with RNA-seq and mass spectrometry approaches

  • This integration provides a systems-level understanding of SPBC215.01 function within cellular networks

How do research methodologies for SPBC215.01 compare to approaches used for similar proteins in budding yeast?

While fission yeast (S. pombe) and budding yeast (S. cerevisiae) are both valuable model organisms, key methodological differences must be considered:

• Extraction protocols:

  • Fission yeast cell walls differ in composition (containing both α-1,3-glucan and β-1,6-branched β-1,3-glucan)

  • More rigorous cell disruption protocols may be needed for fission yeast

• Expression systems:

  • Different promoters and vectors are used in the two yeast systems

  • Consider fission yeast-specific expression systems when creating tagged constructs

• Experimental design advantages:

  • Fission yeast divides by medial fission rather than budding

  • Cell cycle studies may benefit from the more uniform cell division pattern in fission yeast

  • Fission yeast has metazoan-like features in splicing and heterochromatin formation

• Conservation considerations:

  • If studying conserved pathways, note that fission yeast shares many features with human cells that budding yeast lacks

  • Cell cycle regulation, RNA splicing, and heterochromatin assembly are more similar between fission yeast and humans

These comparisons highlight why certain research questions may be better addressed using SPBC215.01 in fission yeast rather than homologs in budding yeast.

How can SPBC215.01 antibody studies contribute to understanding similar proteins and pathways in human cells?

Translational research potential includes:

• Identification of human orthologs:

  • Determine if SPBC215.01 has human homologs through bioinformatic analysis

  • If conservation exists, findings in fission yeast may have direct human relevance

• Conserved regulatory mechanisms:

  • Studies in fission yeast have revealed conservation of core regulatory processes including cell cycle control, checkpoint mechanisms, and stress responses

  • SPBC215.01 findings may reveal fundamental mechanisms conserved in humans

• Disease relevance:

  • If human homologs exist, investigate connections to human disease

  • Many human disease genes have functional homologs in fission yeast

• Methodological transfer:

  • Protocols developed for SPBC215.01 antibody in fission yeast may be adaptable to human cell studies

  • Consider epitope conservation when designing antibodies against human homologs